Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ypeginterferon alfa-2b in Chinese Chronic Hepatitis C
NCT01581398Phase 3Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Apr 2012
- Primary completion
- Apr 2014
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b in hepatitis C (HCV), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Apr 2012; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01581398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581398.